Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 6-(1h-indol-4-yl)-4-(5-((4-(1-methylethyl)-1-piperazinyl)methyl)-1,3-oxazol-2-yl)-1h-indazole
2. Gsk2269557
1. 1254036-71-9
2. Gsk-2269557 Free Base
3. Gsk2269557
4. Nemiralisib [usan]
5. Oep8jj3ozr
6. Gsk2269557a
7. 2-[6-(1h-indol-4-yl)-1h-indazol-4-yl]-5-[(4-propan-2-ylpiperazin-1-yl)methyl]-1,3-oxazole
8. Chembl2216859
9. Gsk2269557 (free Base)
10. Gsk-2269557a
11. 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole
12. 1h-indazole, 6-(1h-indol-4-yl)-4-(5-((4-(1-methylethyl)-1-piperazinyl)methyl)-2-oxazolyl)-
13. 1h-indazole, 6-(1h-indol-4-yl)-4-[5-[[4-(1-methylethyl)-1-piperazinyl]methyl]-2-oxazolyl]-
14. 6-(1h-indol-4-yl)-4-(5-((4-(1-methylethyl)-1-piperazinyl)methyl)-1,3-oxazol-2-yl)-1h-indazole
15. Gsk2269557 Free Base
16. Unii-oep8jj3ozr
17. Nemiralisib [inn]
18. Nemiralisib (usan/inn)
19. Nemiralisib [who-dd]
20. Schembl109919
21. Gtpl9425
22. Pi3kdelta Inhibitor Gs2269557
23. Ex-a5754
24. Bdbm50004529
25. Hy-19535a
26. S7937
27. Zinc95564436
28. Ccg-269127
29. Compound 2 [pmid: 26301626]
30. Cs-5683
31. Ac-35584
32. Da-36928
33. Ft-0716060
34. D11267
35. Q27467143
36. 2-(6-(1h-indol-4-yl)-1h-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole
37. 4-(5-(4-isopropyl-1-piperazinyl)methyl-2-oxazolyl)-6-(1h-indole-4-yl)-1h-indazole
38. 6-(1h-indol-4-yl)-4-(5-((4-(1-methylethyl)-1-piperazinyl)methyl)-2-oxazolyl)-1h-indazole
39. Vvx
| Molecular Weight | 440.5 g/mol |
|---|---|
| Molecular Formula | C26H28N6O |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 440.23245954 g/mol |
| Monoisotopic Mass | 440.23245954 g/mol |
| Topological Polar Surface Area | 77 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 655 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
29
PharmaCompass offers a list of Nemiralisib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nemiralisib manufacturer or Nemiralisib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nemiralisib manufacturer or Nemiralisib supplier.
PharmaCompass also assists you with knowing the Nemiralisib API Price utilized in the formulation of products. Nemiralisib API Price is not always fixed or binding as the Nemiralisib Price is obtained through a variety of data sources. The Nemiralisib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nemiralisib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nemiralisib, including repackagers and relabelers. The FDA regulates Nemiralisib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nemiralisib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nemiralisib supplier is an individual or a company that provides Nemiralisib active pharmaceutical ingredient (API) or Nemiralisib finished formulations upon request. The Nemiralisib suppliers may include Nemiralisib API manufacturers, exporters, distributors and traders.
Nemiralisib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nemiralisib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nemiralisib GMP manufacturer or Nemiralisib GMP API supplier for your needs.
A Nemiralisib CoA (Certificate of Analysis) is a formal document that attests to Nemiralisib's compliance with Nemiralisib specifications and serves as a tool for batch-level quality control.
Nemiralisib CoA mostly includes findings from lab analyses of a specific batch. For each Nemiralisib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nemiralisib may be tested according to a variety of international standards, such as European Pharmacopoeia (Nemiralisib EP), Nemiralisib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nemiralisib USP).
